Compare Eli Lilly And Co (LLY) vs PPG Industries, Inc. (PPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs PPG Industries, Inc. — how do they compare? Eli Lilly And Co trades at $1,220.55 (market cap $1.08T), while PPG Industries, Inc. trades at $115.82 (market cap $25.82B). The key difference: Eli Lilly And Co is far larger — about 41.8× PPG Industries, Inc.'s market cap, and PPG Industries, Inc. pays the higher dividend (2.55%). Which is the better fit depends on your goals.
| LLY | PPG | |
|---|---|---|
Market Cap | $1.08T | $25.82B |
Sector | Health | Basic Materials |
52-Week High | $1.24K | $131.56 |
52-Week Low | $639.43 | $94.34 |
Enterprise Value | $1.13T | $31.69B |
Dividend Yield | 0.57% | 2.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,223.97, down 0.62% on the day, maintaining strong bullish momentum with consecutive earnings beats and robust revenue growth. The stock shows technical strength above key support levels at $1,207, while fundamentals reveal exceptional profitability with 33.53% net margins and 102.44% ROE. Recent quarterly results exceeded expectations, with Q2 2026 revenue surging 48% to $23 billion driven by Mounjaro and Zepbound demand.
Outlook remains positive with analyst consensus targeting $1,380 and 73% buy ratings, though elevated valuations (P/E 40.8) and regulatory risks around weight-loss drug competition present headwinds. The company's pipeline advancement with retatrutide filing expected in 2027 provides medium-term growth catalysts, but investors should monitor execution risks in the competitive obesity drug market.
PPG Industries trades at $114.61, down 0.74% on the day, with mixed technical signals showing a neutral overall outlook. The company reported Q2 2026 earnings of $2.23 per share, slightly missing estimates despite 7% revenue growth. Fundamentals remain solid with a 9.57% net margin and 19.63% ROE, while valuation metrics appear reasonable with a P/E of 16.67. Recent developments include a dividend increase to $0.74 per share and leadership changes in Industrial Coatings.
PPG presents a balanced investment case with strong profitability and shareholder returns offset by recent earnings misses. The 12% upside to consensus price target of $129.17 suggests moderate growth potential, though investors face risks from raw material cost pressures and competitive market conditions. The company's consistent dividend history and improving cash flow support long-term value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →
